IL-17 modulator 1

• UNSPSC Description:

  IL-17 modulator 1 is an orally active, highly efficacious small molecule IL-17 modulators extracted from patent WO 2020127685. IL-17 modulator 1 can be used for the research of preventing, researching or ameliorating a variety of diseases including psoriasis, ankylosing spondylitis and psoriatic arthritis[1].

• Target Antigen:

  Interleukin Related

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/il-17-modulator-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=NN1C(C)C)N[C@H](C(NC2=CC=C(C3=C(N(N=C3C)COP(O)(O)=O)C)C=C2)=O)C(C4CC4)C5CC5

• Molecular Weight:

  584.60

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2446803-85-4